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Abstract The effects of the WT on store-mediated Ca 2+ entry 
and protein tyrosine phosphorylation were investigated in fura-2- 
loaded human platelets. Wortmannin (2 laM) attenuated the rise 
in [Ca2+]i caused by Ca 2÷ entry while having no effect on the 
mobilisation of Ca 2+ from internal stores. It also reduced store- 
depletion-evoked protein tyrosine phosphorylation. These find- 
ings demonstrate that WT is an inhibitor of tyrosine phosphor- 
ylation and store-mediated calcium entry and provide further 
evidence for the involvement of a tyrosine phosphorylation step in 
the link between Ca 2÷ store depletion and Ca 2+ influx in human 
platelets. 
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1. Introduction 
In many cell types including human platelets, depletion of 
intracellular Ca 2+ stores evokes influx of Ca 2+ across the 
plasma membrane [1-3]. However, the mechanism of this 
store-mediated (or 'capacitative') Ca 2+ entry [4] remains un- 
certain. One proposal is that protein tyrosine phosphorylation 
plays a role. Vostal and coworkers uggested that cytosolic 
and intracellular store Ca 2+ antagonistically control tyrosine 
phosphorylation a d hence Ca 2÷ entry in human platelets [5]. 
In this model, store-depletion is proposed to activate a tyro- 
sine kinase resulting in enhanced tyrosine phosphorylation 
and hence promotion of Ca 2+ influx. Internal store refilling 
is proposed to activate a tyrosine phosphatase which would 
reduce tyrosine phosphorylation and terminate Ca 2+ influx 
[5]. This hypothesis i supported by the finding that various 
known tyrosine kinase inhibitors reduce Ca 2+ entry evoked by 
agonists and by store-depletion in platelets whilst having little 
or no effect on the release of Ca 2+ from intracellular stores [6, 
7]. Similar results have been reported with other cell types [8- 
10]. We have shown that depletion of the intracellular Ca 2+ 
store in platelets results in an increase in protein tyrosine 
phosphorylation which is reversed when the stores are refilled 
with divalent cations [11]. The ability of refilling with a par- 
ticular divalent cation to reduce tyrosine phosphorylation cor- 
relates with its ability to reduce Mn 2+ entry [11]. These ob- 
servations upport the existence of a tyrosine phosphatase 
activity associated with full intracellular Ca 2+ stores. 
The fungal metabolite wortmannin (WT) has been shown to 
inhibit several agonist evoked platelet responses including ser- 
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otonin secretion and aggregation [12]. In a number of cell 
types, including platelets, WT has been reported to suppress 
Ca 2-- entry evoked by both agonists and store-depletion 
[13,14]. Hence, we have investigated the effects of WT on 
store-depletion evoked Ca 2+ influx and protein tyrosine phos- 
phorylation in human platelets. 
2. Materials and methods 
2.1. Materials 
Fura-2/AM was from Molecular Probes (Eugene, OR, USA). Apyr- 
ase (grade V), aspirin, thapsigargin a d WT were from Sigma (Poole, 
Dorset, UK). Ionomycin was from Calbiochem (Nottingham, UK). 
All other reagents were of analytical grade. 
2.2. Methods 
Human platelets were prepared as described elsewhere [1]. Briefly, 
platelet-rich plasma was incubated at 37°C with 2 gM Fura-2/AM for 
45 min. Cells were collected by centrifugation and resuspended in 
Hepes-buffered saline (145 mM NaCI, 5 mM KC1, 10 mM NaHepes, 
1 mM MgSO4, 10 mM D-glucose, 20 gg/ml apyrase, pH 7.4 at 37°C). 
Fluorescence was recorded from aliquots of stirred platelet suspen- 
sions at 370C using a Cairn Research Spectrophotometer (Cairn Re- 
search Ltd., Sittingbourne, Kent, UK) with excitation wavelengths of 
340 and 380 nm and emission at 500 nm. Changes in [Ca2+]i were 
monitored using the 340/380 nm fluorescence ratio and calibrated 
according to the method of Grynkiewicz et al. [15]. 
Protein tyrosine phosphorylation was detected by gel electrophor- 
esis and Western blotting using a specific anti-phosphotyrosine a ti- 
body essentially asdescribed previously [6] but blocking with 10% (w/ 
v) bovine serum albumin instead of milk protein. Densitometric meas- 
urements were made with the use of a Quantimet 500 densitometer 
(Leica, Milton Keynes, UK). 
3. Results and discussion 
Fig. 1 shows the effect of WT on the change in platelet 
[Ca2+]i following the sequential additions of thapsigargin 
and Ca 2+ to platelets initially in the absence of external 
Ca 2+ (presence of 0.5 mM EGTA). Preincubation with WT 
had no effect on the thapsigargin-evoked [Ca2+]i rise. After 
addition of thapsigargin the mean peak [Ca2+]i elevations 
above basal were 45+5 nM (mean+S.E.M.) in controls, 
52 + 7 nM with 100 nM WT (Student's paired t test, difference 
of means, 0.5 > P>0.1,  n=7) and 39+6 nM with 2 gM WT 
(0.1 > P > 0.05, n = 8). However, preincubation with 2 gM 
WT significantly reduced the rise in [Ca2+]i occurring after 
the addition of 2 mM Ca 2+ (Fig. lb). The peak of the rise 
in [Ca2+]i on Ca 2+ addition was 549 + 96 nM in the presence 
of WT compared with 1079+ 135 nM in controls 
(0.01 > P> 0.001, n = 8). At a lower concentration of WT 
(100 nM), there was no effect on Ca 2+ entry after addition 
of external Ca 2+ (Fig. lc). After the addition of Ca 2+ the peak 
[Ca2+]i rise was 1110+281 nM in the presence of WT com- 
pared with 1286+216 nM in controls (0 .5>P>0.1,  n=7). 
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Fig. 1. The effect of WT on the [Ca2+]i elevation evoked by thapsi- 
gargin. Fluorescence recordings from fura-2-1oaded human platelets 
incubated, for 10 min at 37°C, with either 2 ~tM WT (b), 100 nM 
WT (c), or the vehicle, DMSO (a), in the presence of 0.5 mM 
EGTA. 250 nM thapsigargin (TG) was added as indicated, followed 
by the subsequent addition of 2 mM Ca 2+ to assess Ca 2+ entry. 
These data demonstrate that WT at high concentrations at- 
tenuates tore-depletion evoked calcium entry while having no 
affect on the thapsigargin-evoked mobilisation of Ca 2+ from 
internal stores. 
Next we examined the effect of WT on store-depletion 
evoked tyrosine phosphorylation i platelets. Samples were 
taken during the time course of the fluorescence experiments 
and protein tyrosine phosphorylation determined. Typical re- 
sults are shown in Fig. 2. A 10 min incubation with 2 ~M WT 
decreased protein tyrosine phosphorylation evoked by store 
depletion with inhibition most evident at specific bands of 
approximately 57, 69 and 130 kDa. Wortmannin, at this con- 
centration, also suppresses thrombin-evoked protein tyrosine 
phosphorylation (data not shown). Incubation with the lower 
concentration of WT (100 nM) did not affect the phosphotyr- 
osine levels. These effects are quantified in Fig. 3, which shows 
mean integrated absorbencies of the entire lane from the pro- 
tein phosphotyrosine analysis of three experiments. Results 
are expressed as a percentage of the integrated optical density 
of platelets before stimulation. Hence, at high concentrations, 
WT almost completely suppressed the rise in tyrosine phos- 
phorylation evoked by depletion of the intracellular calcium 
stores. Therefore at micromolar concentrations, WT is a po- 
tent tyrosine kinase inhibitor and greatly reduces tore deple- 
tion-evoked protein tyrosine phosphorylation. Wortmannin 
has also been reported to inhibit tyrosine phosphorylation 
in human neutrophils [16]. 
Similar effects of high concentrations of WT on thapsigar- 
gin-evoked Ca z+ entry in human platelets have been reported 
previously [14]. This inhibition was suggested to result from a 
specific inhibition of myosin-light chain kinase which was 
therefore proposed to play a role in Ca 2+ entry [14]. Our 
results show that WT leads to inhibition of protein tyrosine 
phosphorylation within the cell an effect which reduces tore- 
mediated Ca 2+ influx [5-11]. 
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Fig. 2. The effect of WT on store-depletion-evoked protein tyrosine 
phosphorylation. 200 ].tM aliquots were taken from a stirred fura-2- 
loaded platelet suspension at 20 s prior to (a), and 10 s (b) and 
105 s (c) after, the addition of 250 nM thapsigargin with 50 nM io- 
nomycin. Platelet suspensions were pre-incubated for 10 min at 
37°C with either 2 taM WT (right hand lanes) or control, DMSO 
(left hand lanes). Proteins were analysed by 8% SDS-PAGE and 
subsequent Western blotting with a specific antiphosphotyrosine 
antibody. 
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Fig. 3. Densitometric measurements of the phosphotyrosine analysis, 
Three experiments were performed as described for Fig. 2 on plate- 
lets from three different donors and the presence of phosphotyrosine 
residues quantified by densitometry. The data represent the inte- 
grated optical density (mean+ SEM) for the entire lane 105 s after 
the thapsigargin and ionomycin addition. 
In human neutrophils, WT attenuates N-formyl-Met-Leu- 
Phe (fMLP) receptor-mediated phospholipase-D activation, 
without directly affecting the phospholipase activity [17]. 
This was later found to correlate with an inhibition of phos- 
phoinositide 3-kinase (PI 3-kinase) upstream of the phospho- 
lipase [18]. At concentrations of i00 nM or less WT has been 
shown to specifically and directly block PI 3-kinase [19]. At 
this concentration WT had no affect on store-mediated cal- 
cium influx or protein tyrosine phosphorylation. Conse- 
quently, the observed effects at high concentrations is unlikely 
to be due to a specific inhibition of PI 3-kinase. In a recent 
report in Swiss 3T3 cells, WT was demonstrated to be a po- 
tent inhibitor of phospholipase A2, as well as PI 3-kinase, at 
nM concentrations [20]. However, inhibition of phospholipase 
A 2 cannot explain observations reported here as aspirinated 
platelets were used. 
4. Conclusions 
In summary, we have demonstrated that WT at micromolar 
concentrations effectively suppresses tore-depletion evoked 
calcium influx while having no affect on the thapsigargin- 
evoked mobilisation of Ca 2+ from internal stores. At the 
same concentrations WT also reduced store-depletion-evoked 
protein tyrosine phosphorylation. Concentrations in the range 
at which wortmannin i hibits PI-3 kinase were without these 
effects. Hence, at micromolar concentrations, WT acts as a 
non-specific tyrosine kinase inhibitor. These findings are com- 
patible with a role for the involvement of a tyrosine phos- 
phorylation step in the link between depletion of Ca 2+ stores 
and Ca 2+ entry in human platelets. 
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